Rodon, Jordi, Medical Oncology, Vall d’Hebron, Barcelona, Spain
-
Vol. 5, No. 11, Nov 2014 - Case Reports
Case Series of Cancer Patients Treated With Galunisertib, a Transforming Growth Factor-Beta Receptor I Kinase Inhibitor in a First-in-Human Dose Study
Abstract HTML PDF